The reduction in CT26 tumor volume following VEGF121/rGel-PCI enhanced αCTLA4, as measured on day 4 relative to initial volume (Figure 7B), was found significant (p < 0.05, one way ANOVA test) after+ 16.5μgx1 and 50μgx1 αCTLA4, but not 5μgx1. This evidence concerns the gene DDX53 and neoplasm.